Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis
Chow R, Navari RM, Terry B, DeAngelis C, Prsic EH. Olanzapine 5 mg vs 10 mg for the prophylaxis of chemotherapy-induced nausea and vomiting: a network meta-analysis. Supportive Care In Cancer 2021, 30: 1015-1018. PMID: 34613472, DOI: 10.1007/s00520-021-06606-x.Peer-Reviewed Original ResearchMeSH KeywordsAntiemeticsAntineoplastic AgentsBenzodiazepinesHumansNauseaNetwork Meta-AnalysisOlanzapineVomitingCancer-related fatigue—pharmacological interventions: systematic review and network meta-analysis
Chow R, Bruera E, Sanatani M, Chiu L, Prsic E, Boldt G, Lock M. Cancer-related fatigue—pharmacological interventions: systematic review and network meta-analysis. BMJ Supportive & Palliative Care 2021, 13: 274-280. PMID: 34593386, DOI: 10.1136/bmjspcare-2021-003244.Peer-Reviewed Original ResearchMeSH KeywordsCentral Nervous System StimulantsFatigueHumansMethylphenidateModafinilNeoplasmsNetwork Meta-AnalysisParoxetineConceptsCancer-related fatiguePharmacologic interventionsSystematic reviewCochrane Central RegisterFuture clinical trialsMore safety dataCentral RegisterHead trialsControlled TrialsCommon symptomsFuture trialsClinical trialsSafety dataDirect headMean differenceParoxetineModafinilTrialsInterventionPatientsCancer researchReviewPlaceboEMBASEMEDLINE